2011 ACCF/AHA Health Policy Statement on Therapeutic Interchange and Substitution.
Why aren’t Biosimilars Generics – Regulatory Challenges Adam Sabouni, PhD PharmaConsultz 4 th International Conference on Pharmaceutical Regulatory Affairs.
